Many organizations are operating with constrained resources while trying to expand, launch new therapies, or scale ...

Unichem Laboratories Limited has informed that the United States Food and Drug Administration (USFDA) has concluded an inspection of the company's Kolhapur active ...

Unichem Laboratories said the USFDA inspected its Kolhapur API facility, closing the audit with five procedural observations. Shares ended higher even as Q3 profit fell 20.5% year-on-year.

Unichem Laboratories said the United States Food and Drug Administration (USFDA) inspected its Kolhapur API facility from 27 January to 2 February 2026.

The pharmaceutical industry operates under an uncompromising mandate: zero defects. Every tablet, capsule, vial, or syringe must meet exacting standards for dosage, purity, and sterility. This ...

With a potential US government shutdown looming, Megha Sinha, Kamet Consulting, says to treat FDA disruptions as predictable risks by protecting milestones and early readiness.

Opportunities center on delivering comprehensive GCP training that covers recent regulatory updates, the EU Clinical Trials Regulation, and ICH GCP R3. Interactive courses that address new tech in ...

The integrated solution delivers a shift-left approach to cybersecurity, enabling executive teams to proactively embed security, quality, and compliance from early development to post-market. When ...

Opportunities lie in enhancing data integrity auditing skills within pharmaceutical manufacturing, focusing on GxP audits. Companies can capitalize by offering comprehensive training that delves into ...

Zydus Lifesciences share price rose in the early trade on January 27 despite the company received three observations from the ...

This guide explores how regulated laboratories can achieve strong data integrity by digitalizing key processes ...